-transparent.png){kind=logo}
Viruses may be eliminated by the host immune system via complement-mediated lysis of infected cells. Previously, we have demonstrated that the synthesis of complement factor B by renal mesangial cells (MC) is enhanced by interferon-alpha (IFN-alpha), -beta and -gamma. In the present study we investigate the effect of human cytomegalovirus (HCMV) infection on the production of complement factors by MC. The production of factor B, C2, C4 and factor H by mock-infected MC was 0.2 +/- 0.4, 3.9 +/- 6.8, 1.7 +/- 0.8 and 149 +/- 36 ng/10(6) cells per 72 h, respectively. In HCMV-infected MC cultures an induction of both factor B and C2 protein synthesis was observed up to 2.2 +/- 1.1 and 156 +/- 74 ng/10(6) cells per 72 h, respectively. The synthesis of C4 and factor H of 2.9 +/- 2.0 and 146 +/- 31 ng/10(6) cells, respectively, was not altered significantly. By Northern blot and reverse transcriptase-polymerase chain reaction (RT-PCR) analysis it was demonstrated that factor B and C2 mRNA expression were up-regulated in HCMV-infected cell cultures, whereas the levels of C4 and factor H mRNA were not changed. When MC cultures were inoculated with heat- or UV-inactivated HCMV no enhancement of factor B mRNA expression was observed. The enhanced expression was not blocked by phosphono acetic acid (PAA), suggesting that expression of the HCMV immediate early or early genes is sufficient to induce complement synthesis. We conclude that infection of MC cultures with HCMV selectively induces complement C2 and factor B production, probably mediated by interferons.
J J Timmerman, and
M F Beersma, and
D J van Gijlswijk-Janssen, and
L A van Es, and
F J van der Woude, and
M R Daha
November 2003,
Kidney international,
J J Timmerman, and
M F Beersma, and
D J van Gijlswijk-Janssen, and
L A van Es, and
F J van der Woude, and
M R Daha
July 1995,
Journal of immunology (Baltimore, Md. : 1950),
J J Timmerman, and
M F Beersma, and
D J van Gijlswijk-Janssen, and
L A van Es, and
F J van der Woude, and
M R Daha
July 2004,
Kidney international,
J J Timmerman, and
M F Beersma, and
D J van Gijlswijk-Janssen, and
L A van Es, and
F J van der Woude, and
M R Daha
October 1994,
Kidney international,
J J Timmerman, and
M F Beersma, and
D J van Gijlswijk-Janssen, and
L A van Es, and
F J van der Woude, and
M R Daha
January 1994,
Experimental nephrology,
J J Timmerman, and
M F Beersma, and
D J van Gijlswijk-Janssen, and
L A van Es, and
F J van der Woude, and
M R Daha
September 1992,
The Journal of laboratory and clinical medicine,
J J Timmerman, and
M F Beersma, and
D J van Gijlswijk-Janssen, and
L A van Es, and
F J van der Woude, and
M R Daha
March 1988,
Proceedings of the National Academy of Sciences of the United States of America,
J J Timmerman, and
M F Beersma, and
D J van Gijlswijk-Janssen, and
L A van Es, and
F J van der Woude, and
M R Daha
May 2010,
Transplantation proceedings,
J J Timmerman, and
M F Beersma, and
D J van Gijlswijk-Janssen, and
L A van Es, and
F J van der Woude, and
M R Daha
January 1993,
Cytotechnology,
J J Timmerman, and
M F Beersma, and
D J van Gijlswijk-Janssen, and
L A van Es, and
F J van der Woude, and
M R Daha
January 1993,
Cytotechnology,
